{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:23:47Z","timestamp":1791685427299,"version":"4.3.4"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG0623199"],"award-info":[{"award-number":["R01AG0623199"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG60766"],"award-info":[{"award-number":["R01AG60766"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"ADDF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012202","name":"Lucas Brothers Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.trsl.2022.10.009","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T04:19:00Z","timestamp":1667535540000},"page":"34-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Targeting caspase-2 interactions with tau in Alzheimer's disease and related dementias"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-9868","authenticated-orcid":false,"given":"Steffen","family":"Pockes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Ashe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2022.10.009_bib0001","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1523\/JNEUROSCI.22-22-09733.2002","article-title":"Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease","volume":"22","author":"Fath","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2022.10.009_bib0002","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.1152993","article-title":"Differential regulation of dynein and kinesin motor proteins by tau","volume":"319","author":"Dixit","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.trsl.2022.10.009_bib0003","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.neuron.2015.01.025","article-title":"Pathological tau disrupts ongoing network activity","volume":"85","author":"Menkes-Caspi","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.trsl.2022.10.009_bib0004","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.trsl.2022.10.009_bib0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/bs.ircmb.2016.12.002","article-title":"Old and novel functions of caspase-2","volume":"332","author":"Miles","year":"2017","journal-title":"Int Rev Cell Mole Biol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0006","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cell.2009.08.021","article-title":"Caspases and kinases in a death grip","volume":"138","author":"Kurokawa","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2022.10.009_bib0007","doi-asserted-by":"crossref","first-page":"e1198","DOI":"10.1038\/tp.2017.165","article-title":"Abolishing Tau cleavage by caspases at Aspartate421 causes memory\/synaptic plasticity deficits and pre-pathological Tau alterations","volume":"7","author":"Biundo","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.trsl.2022.10.009_bib0008","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11064-015-1752-5","article-title":"The role of proteases in hippocampal synaptic plasticity: putting together small pieces of a complex puzzle","volume":"41","author":"Salazar","year":"2016","journal-title":"Neurochem Res"},{"key":"10.1016\/j.trsl.2022.10.009_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms2927","article-title":"Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice","volume":"4","author":"Pozueta","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2022.10.009_bib0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20041142","article-title":"The protein structures that shape caspase activity, specificity, activation and inhibition","volume":"384","author":"Fuentes-Prior","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.trsl.2022.10.009_bib0011","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41418-018-0110-y","article-title":"Caspase selective reagents for diagnosing apoptotic mechanisms","volume":"26","author":"Poreba","year":"2019","journal-title":"Cell Death Different"},{"key":"10.1016\/j.trsl.2022.10.009_bib0012","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ceb.2003.10.009","article-title":"Mechanisms of caspase activation","volume":"15","author":"Boatright","year":"2003","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0013","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.cdd.4401160","article-title":"Many cuts to ruin: a comprehensive update of caspase substrates","volume":"10","author":"Fischer","year":"2003","journal-title":"Cell Death Different"},{"key":"10.1016\/j.trsl.2022.10.009_bib0014","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/cdd.2011.157","article-title":"Caspase-2: the orphan caspase","volume":"19","author":"Bouchier-Hayes","year":"2012","journal-title":"Cell Death Different"},{"key":"10.1016\/j.trsl.2022.10.009_bib0015","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.yexcr.2006.03.027","article-title":"Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs","volume":"312","author":"Cheung","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.trsl.2022.10.009_bib0016","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/cdd.2012.54","article-title":"PIDDosome-independent tumor suppression by Caspase-2","volume":"19","author":"Manzl","year":"2012","journal-title":"Cell Death Different"},{"key":"10.1016\/j.trsl.2022.10.009_bib0017","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrc2745","article-title":"Caspase 2 in apoptosis, the DNA damage response and tumour suppression: enigma no more?","volume":"9","author":"Kumar","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2022.10.009_bib0018","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tcb.2009.12.006","article-title":"The unpredictable caspase-2: what can it do?","volume":"20","author":"Vakifahmetoglu-Norberg","year":"2010","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0019","doi-asserted-by":"crossref","first-page":"e2096","DOI":"10.1038\/cddis.2016.19","article-title":"Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease","volume":"7","author":"Machado","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2022.10.009_bib0020","unstructured":"Diehl AME, Michelotti GA, Machado MV, Kornbluth SA, Seager-Johnson E, Lindblom KR. Use of caspase-2 inhibitors to treat and prevent the metabolic syndrome. Published online 2016."},{"key":"10.1016\/j.trsl.2022.10.009_bib0021","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cell.2018.08.020","article-title":"ER stress drives lipogenesis and steatohepatitis via caspase-2 activation of S1P","volume":"175","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2022.10.009_bib0022","doi-asserted-by":"crossref","first-page":"e53473","DOI":"10.1371\/journal.pone.0053473","article-title":"Pharmacological inhibition of caspase-2 protects axotomised retinal ganglion cells from apoptosis in adult rats","volume":"7","author":"Vigneswara","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.trsl.2022.10.009_bib0023","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2016.44","article-title":"Long-term neuroprotection of retinal ganglion cells by inhibiting caspase-2","volume":"2","author":"Vigneswara","year":"2016","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.trsl.2022.10.009_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-11575-1","article-title":"Caspase-2 promotes AMPA receptor internalization and cognitive flexibility via mTORC2-AKT-GSK3\u03b2 signaling","volume":"10","author":"Xu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2022.10.009_bib0025","doi-asserted-by":"crossref","first-page":"16368","DOI":"10.1073\/pnas.0806222105","article-title":"The PIDDosome mediates delayed death of hippocampal CA1 neurons after transient global cerebral ischemia in rats","volume":"105","author":"Niizuma","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.trsl.2022.10.009_bib0026","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/pr.2012.15","article-title":"Combined effect of hypothermia and caspase-2 gene deficiency on neonatal hypoxic\u2013ischemic brain injury","volume":"71","author":"Carlsson","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1016\/j.trsl.2022.10.009_bib0027","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bone.2015.03.006","article-title":"Caspase-2 modulates osteoclastogenesis through down-regulating oxidative stress","volume":"76","author":"Callaway","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.trsl.2022.10.009_bib0028","first-page":"330","article-title":"Loss of caspase-2,-6 and-7 expression in gastric cancers","volume":"112","author":"Yoo","year":"2004","journal-title":"Apmis"},{"key":"10.1016\/j.trsl.2022.10.009_bib0029","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood-2004-11-4296","article-title":"Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia","volume":"106","author":"Holleman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2022.10.009_bib0030","first-page":"321","article-title":"Gene expression profiling of metastatic brain cancer","volume":"18","author":"Zohrabian","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.trsl.2022.10.009_bib0031","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1134\/S0026893318050060","article-title":"Caspase-2 as an oncosupressor and metabolism regulator: what life will bring over the long run?","volume":"52","author":"AYu","year":"2018","journal-title":"Mole Biol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0032","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/cdd.2013.87","article-title":"Caspase-2 as a tumour suppressor","volume":"20","author":"Puccini","year":"2013","journal-title":"Cell Death Differentiation"},{"key":"10.1016\/j.trsl.2022.10.009_bib0033","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1101\/gad.12.9.1304","article-title":"Defects in regulation of apoptosis in caspase-2-deficient mice","volume":"12","author":"Bergeron","year":"1998","journal-title":"Genes Develop"},{"key":"10.1016\/j.trsl.2022.10.009_bib0034","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mad.2006.11.030","article-title":"Caspase-2 deficiency enhances aging-related traits in mice","volume":"128","author":"Zhang","year":"2007","journal-title":"Mechan Age Develop"},{"key":"10.1016\/j.trsl.2022.10.009_bib0035","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/nm.4199","article-title":"Caspase-2 cleavage of tau reversibly impairs memory","volume":"22","author":"Zhao","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2022.10.009_bib0036","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1523\/JNEUROSCI.20-04-01386.2000","article-title":"Caspase-2 mediates neuronal cell death induced by \u03b2-amyloid","volume":"20","author":"Troy","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2022.10.009_bib0037","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/jnen\/64.2.104","article-title":"The role of caspase cleavage of tau in Alzheimer disease neuropathology","volume":"64","author":"Cotman","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0038","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0039","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/NEN.0000000000000013","article-title":"Proteolytic cleavage of polymeric tau protein by caspase-3: implications for Alzheimer disease","volume":"72","author":"Jarero-Basulto","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0040","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s12035-017-0385-x","article-title":"Caspase-cleaved tau impairs mitochondrial dynamics in Alzheimer's disease","volume":"55","author":"P\u00e9rez","year":"2018","journal-title":"Mole Neurobiol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0041","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1042\/BST0380955","article-title":"Proteolytic processing of tau","volume":"38","author":"Wang","year":"2010","journal-title":"Biochem Soc Transact"},{"key":"10.1016\/j.trsl.2022.10.009_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-021-03506-0","article-title":"Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits","volume":"12","author":"No\u00ebl","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2022.10.009_bib0043","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer's disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.trsl.2022.10.009_bib0044","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nature08890","article-title":"Caspase activation precedes and leads to tangles","volume":"464","author":"De Calignon","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.10.009_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.590754","article-title":"Tau filament self-assembly and structure: tau as a therapeutic target","volume":"11","author":"Oakley","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0046","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1073\/pnas.1630428100","article-title":"Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease","volume":"100","author":"Gamblin","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.trsl.2022.10.009_bib0047","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200420640","article-title":"Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology","volume":"114","author":"Rissman","year":"2004","journal-title":"J Clin Investig"},{"key":"10.1016\/j.trsl.2022.10.009_bib0048","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1042\/EBC20210028","article-title":"Targeted proteolytic products of \u03c4 and \u03b1-synuclein in neurodegeneration","volume":"65","author":"Xia","year":"2021","journal-title":"Essays Biochem"},{"key":"10.1016\/j.trsl.2022.10.009_bib0049","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/nm.4227","article-title":"Caspase-2 and tau\u2014a toxic partnership?","volume":"22","author":"Troy","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2022.10.009_bib0050","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.trsl.2022.10.009_bib0051","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrn2867","article-title":"Long-term depression in the CNS","volume":"11","author":"Collingridge","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.trsl.2022.10.009_bib0052","first-page":"1","article-title":"A soluble truncated tau species related to cognitive dysfunction is elevated in the brain of cognitively impaired human individuals","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2022.10.009_bib0053","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-019-0765-8","article-title":"A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease","volume":"7","author":"Smith","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.trsl.2022.10.009_bib0054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-019-0764-9","article-title":"A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington's disease patients","volume":"7","author":"Liu","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.trsl.2022.10.009_bib0055","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1523\/JNEUROSCI.0543-22.2022","article-title":"Blocking site-specific cleavage of human tau delays progression of disease-related phenotypes in genetically matched tau-transgenic mice modeling frontotemporal dementia","volume":"42","author":"Steuer","year":"2022","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2022.10.009_bib0056","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/nprot.2017.091","article-title":"Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity","volume":"12","author":"Poreba","year":"2017","journal-title":"Nat Protocols"},{"key":"10.1016\/j.trsl.2022.10.009_bib0057","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/s41418-019-0329-2","article-title":"Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells","volume":"26","author":"Poreba","year":"2019","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.trsl.2022.10.009_bib0058","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1021\/acsptsci.1c00251","article-title":"Structure-based design and biological evaluation of novel caspase-2 inhibitors based on the peptide AcVDVAD-CHO and the caspase-2-mediated tau cleavage sequence YKPVD314","volume":"5","author":"Bresinsky","year":"2022","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.trsl.2022.10.009_bib0059","unstructured":"Bresinsky M, Strasser JM, Hubmann A, et al. Characterization of caspase-2 inhibitors based on specific sites of caspase-2-mediated proteolysis. Archiv der Pharmazie.:e2200095."},{"key":"10.1016\/j.trsl.2022.10.009_bib0060","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1083\/jcb.149.3.603","article-title":"Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis","volume":"149","author":"Mancini","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0061","doi-asserted-by":"crossref","first-page":"E2001","DOI":"10.1073\/pnas.1524900113","article-title":"Quantitative MS-based enzymology of caspases reveals distinct protein substrate specificities, hierarchies, and cellular roles","volume":"113","author":"Julien","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.trsl.2022.10.009_bib0062","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcel.2011.06.012","article-title":"Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop","volume":"43","author":"Oliver","year":"2011","journal-title":"Mole Cell"},{"key":"10.1016\/j.trsl.2022.10.009_bib0063","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1021\/acschemneuro.2c00100","article-title":"Caspase-2 inhibitor blocks tau truncation and restores excitatory neurotransmission in neurons modeling FTDP-17 tauopathy","volume":"13","author":"Singh","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.trsl.2022.10.009_bib0064","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cmdc.200900531","article-title":"A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety","volume":"5","author":"Boxer","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.trsl.2022.10.009_bib0065","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1016\/j.bmc.2011.08.020","article-title":"Exploiting differences in caspase-2 and -3 S2 subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors","volume":"19","author":"Maillard","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.trsl.2022.10.009_bib0066","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1021\/ci500175r","article-title":"Structure-based virtual screening approach for discovery of covalently bound ligands","volume":"54","author":"Toledo Warshaviak","year":"2014","journal-title":"J Chem Inform Model"},{"key":"10.1016\/j.trsl.2022.10.009_bib0067","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/ci500118s","article-title":"Docking covalent inhibitors: a parameter free approach to pose prediction and scoring","volume":"54","author":"Zhu","year":"2014","journal-title":"J Chem Inform Model"},{"key":"10.1016\/j.trsl.2022.10.009_bib0068","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1021\/acsmedchemlett.6b00491","article-title":"Discovery of GBT440, an orally bioavailable R-state stabilizer of sickle cell hemoglobin","volume":"8","author":"Metcalf","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.trsl.2022.10.009_bib0069","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.trsl.2022.10.009_bib0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-022-00702-0","article-title":"The challenges of anti-tau therapeutics in Alzheimer disease","volume":"18","author":"Panza","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0071","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/d41573-020-00217-7","article-title":"Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.trsl.2022.10.009_bib0072","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnagi.2017.00083","article-title":"Tau oligomers: cytotoxicity, propagation, and mitochondrial damage","volume":"9","author":"Shafiei","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.trsl.2022.10.009_bib0073","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.4103\/1673-5374.306073","article-title":"The molecular implications of a caspase-2-mediated site-specific tau cleavage in tauopathies","volume":"16","author":"Liu","year":"2021","journal-title":"Neural Regener Res"},{"key":"10.1016\/j.trsl.2022.10.009_bib0074","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1750-1326-6-59","article-title":"Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease","volume":"6","author":"Carroll","year":"2011","journal-title":"Mole Neurodegener"},{"key":"10.1016\/j.trsl.2022.10.009_bib0075","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nm.3617","article-title":"Huntington's disease is a four-repeat tauopathy with tau nuclear rods","volume":"20","author":"Fern\u00e1ndez-Nogales","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2022.10.009_bib0076","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.expneurol.2011.03.009","article-title":"A knockout of the caspase 2 gene produces increased resistance of the nigrostriatal dopaminergic pathway to MPTP-induced toxicity","volume":"229","author":"Tiwari","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0077","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2010.04.031","article-title":"Probing the biology of Alzheimer's disease in mice","volume":"66","author":"Ashe","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.trsl.2022.10.009_bib0078","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/alz.12084","article-title":"The biogenesis and biology of amyloid \u03b2 oligomers in the brain","volume":"16","author":"Ashe","year":"2020","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.trsl.2022.10.009_bib0079","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature11028","article-title":"Optogenetic stimulation of a hippocampal engram activates fear memory recall","volume":"484","author":"Liu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.10.009_bib0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nature13294","article-title":"Engineering a memory with LTD and LTP","volume":"511","author":"Nabavi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.10.009_bib0081","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.23964","article-title":"Much of late life cognitive decline is not due to common neurodegenerative pathologies","volume":"74","author":"Boyle","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0082","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ana.25123","article-title":"Person-specific contribution of neuropathologies to cognitive loss in old age","volume":"83","author":"Boyle","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0083","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ana.25380","article-title":"Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies","volume":"85","author":"Boyle","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0084","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.trsl.2022.10.009_bib0085","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1021\/acs.jmedchem.1c01968","article-title":"Structure-guided discovery of Aminoquinazolines as brain-penetrant and selective LRRK2 inhibitors","volume":"65","author":"Keylor","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.trsl.2022.10.009_bib0086","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1038\/cddis.2011.87","article-title":"Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor","volume":"2","author":"Chauvier","year":"2011","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2022.10.009_bib0087","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/jpet.106.111344","volume":"321","author":"Wannamaker","year":"2007","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.trsl.2022.10.009_bib0088","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cbpa.2013.04.016","article-title":"Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story","volume":"17","author":"Stamford","year":"2013","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.trsl.2022.10.009_bib0089","unstructured":"Renslo AR, Arkin MR, Neitz RJ, et al. Caspase 6 inhibitors and uses thereof. 2021, WO\/2004\/002961."}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524422002419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524422002419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:46:55Z","timestamp":1761828415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524422002419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":89,"alternative-id":["S1931524422002419"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2022.10.009","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting caspase-2 interactions with tau in Alzheimer's disease and related dementias","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2022.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}